This document provides guidance on the clinical development of new fibrinolytics in the treatment of patients with ST segment elevation acute myocardial infarction.
Keywords: ST segment elevation, acute coronary syndrome, myocardial infarction, angina, revascularisation, anticoagulants, antithrombotics, stent thrombosis
This document has been superseded by Clinical investigation of new medicinal products for the treatment of acute coronary syndrome